Kaliumlosartanhydrochloorthiazide Eg (Eurogenerics) (Losartan Potassium, Hydrochlorothiazide)

Kaliumlosartanhydrochloorthiazide Eg acts on the renin‑angiotensin‑aldosterone system and renal sodium handling to lower blood pressure.

• Hypertension: provides effective blood‑pressure control in adults.
• Diabetic nephropathy: helps slow progression of kidney damage associated with diabetes.
• Heart failure with reduced ejection fraction: reduces afterload and improves symptoms when combined with standard therapy.

• Losartan potassium selectively blocks AT1 receptors, preventing angiotensin II‑mediated vasoconstriction, aldosterone release and sodium retention. Hydrochlorothiazide inhibits NaCl reabsorption in the distal convoluted tubule, increasing urinary excretion of sodium and water, thereby reducing plasma volume and further lowering arterial pressure.

Kaliumlosartanhydrochloorthiazide Eg may cause a range of adverse reactions.

Common Side Effects

• Dizziness: feeling light‑headed, especially after standing.
• Headache: mild to moderate intensity.
• Fatigue: general tiredness or lack of energy.
• Increased urination: due to the diuretic component.
• Electrolyte imbalance: especially low potassium levels.
• Mild gastrointestinal upset: nausea or abdominal discomfort.

Serious or Rare Side Effects

• Angioedema: swelling of face, lips, tongue or throat.
• Acute kidney injury: sudden decline in renal function.
• Hyperkalemia: elevated blood potassium concentrations.
• Severe dehydration: excessive fluid loss.
• Hepatic injury: abnormal liver enzyme elevations.
• Blood dyscrasias: rare blood cell abnormalities such as agranulocytosis.

Before initiating therapy, clinicians should evaluate patient‑specific factors and monitor for safety.

• Monitor electrolytes: check potassium and sodium levels regularly.
• Assess renal function: evaluate kidney function before and during treatment.
• Avoid in severe hepatic impairment: use with caution or consider alternatives.
• Pregnancy: risk category unknown; discuss potential benefits and risks with a healthcare provider.
• Drug interactions: review concomitant medications for potential interactions.
• Store at ambient temperature: keep in the original pack, protect from moisture and light.

Kaliumlosartanhydrochloorthiazide Eg can interact with several drug classes.

Major Interactions (Avoid)

• Potassium‑sparing diuretics: may cause dangerous hyperkalemia.
• ACE inhibitors or ARBs combined with aliskiren in diabetic patients: increased risk of renal dysfunction.
• Lithium: concomitant use can raise lithium concentrations.

Moderate Interactions (Monitor Closely)

• NSAIDs: may blunt antihypertensive effect and affect renal function.
• CYP2C9 inhibitors (e.g., fluconazole): can increase losartan plasma levels.
• Additional thiazide diuretics or antihypertensives: additive blood‑pressure lowering may require dose adjustment.